Efavirenz use during pregnancy and for women of child-bearing potential

<p>Abstract</p> <p>Background</p> <p>Efavirenz is the preferred non-nucleoside reverse transcriptase inhibitor for first-line antiretroviral treatment in many countries. For women of childbearing potential, advantages of efavirenz are balanced by concerns that it is teratogenic. This paper reviews e...

Cijeli opis

Bibliografski detalji

Glavni autori:	Gray Glenda E, Krause Amanda, Wessels Tina, Venter Francois WD, Urban Michael F, Chersich Matthew F, Luchters Stanley, Viljoen Dennis L
Format:	Artigo
Jezik:	Inglês
Izdano:	BMC 2006-04-01
Serija:	AIDS Research and Therapy
Online pristup:	http://www.aidsrestherapy.com/content/3/1/11
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!